Disease-specific human embryonic stem cell lines placed on NIH Stem Cell Registry

Sep 28th, 2013 · Comments Off

Main Category: Stem Cell Research
Also Included In: Genetics
Article Date: 27 Sep 2013 – 0:00 PDT

Note: Any medical information published on this website is not intended as a substitute for informed medical advice and you should not take any action before consulting with a health care professional. For more information, please read our terms and conditions.


‘This is a huge milestone for King’s, and will allow us to make a major contribution to global stem cell research by having these stem cell lines available to scientists in the USA.

If you write about specific medications or operations, please do not name health care professionals by name.

MLA

‘These research-grade stem cell lines are essential not only to address basic questions in development and disease, but to test and implement technical improvements in culture conditions that might affect hES cell viability and pluripotency.’

Professor Peter Braude, Emeritus Professor of Obstetrics and Gynaecology, King’s College London; and former director of the Stem Cell Programme and the Pre-Implantation Genetic Diagnosis Programme, Guy’s and St Thomas’ NHS Foundation Trust, said: ‘We are delighted that the NIH has found our lines useful and their procurement and consents in line with the strict guidelines that they have set. This achievement is the culmination of over ten years of painstaking research and consistent belief in the scientific usefulness of these very special cells to improve our understanding of genetic disease processes.

Current ratings for:
Disease-specific human embryonic stem cell lines placed on NIH Stem Cell Registry

Scientists from King’s College London have announced that 16 human embryonic stem (hES) cell lines have been approved by the US National Institutes of Health (NIH) and placed on their Stem Cell Registry, making them freely available for federally-funded research in the USA. The stem cell lines, which carry genes for a variety of hereditary disorders such as Huntington’s disease, spinal muscular dystrophy and cystic fibrosis, are considered to be ideal research tools for designing models to understand disease progression, and ultimately in helping scientists develop new treatments for patients.

Please note: If no author information is provided, the source is cited instead.

All opinions are moderated before being included (to stop spam). We reserve the right to amend opinions where we deem necessary.

London, King\’s College. “Disease-specific human embryonic stem cell lines placed on NIH Stem Cell Registry.” Medical News Today. MediLexicon, Intl., 27 Sep. 2013. Web.
27 Sep. 2013. <http://www.medicalnewstoday.com/releases/266612.php>

stem cell research section for the latest news on this subject.

Please use one of the following formats to cite this article in your essay, paper or report:

For any corrections of factual information, or to contact the editors please use our feedback form.

Please send any medical news or health news press releases to:

Contact Our News Editors

APA

The sixteen lines of stem cells on the NIH Registry carry genes for various hereditary disorders including Duchenne Muscular Dystrophy, Huntington’s disease, cystic fibrosis, and rarer conditions such as Von Hippel-Lindau Syndrome, Wiskott-Aldrich syndrome, spinal muscular atrophy, myotonic dystrophy and neurofibromatosis.


privacy policy for more information.

King’s is now one of the five biggest providers of disease-specific human embryonic stem cells lines on the NIH Registry, and the largest from the UK. The development is a significant milestone for King’s and keeps the university at the forefront of global research into regenerative medicine.

Dr Dusko Ilic, Senior Lecturer in Stem Cell Science at King’s College London, said: ‘I’m delighted that the NIH has accepted our stem cell lines. There are now significant opportunities for US-based researchers to use these lines as tools to test the molecular mechanisms of common diseases, so it’s fantastic that they are now freely available to advance the science of stem cell therapy and regenerative medicine.’

Embryonic stem cell lines are grown from frozen embryos donated by patients undergoing preimplantation genetic diagnosis (PGD) in conjunction with IVF treatment. Unlike ‘adult’ stem cells, embryonic stem cells can differentiate into any type of cell within the body and are considered to be more useful for stem cell-based therapies. Disease-specific stem cell lines are created from embryos found to be affected with genetic disorders and therefore not suitable for implantation, but offer huge potential for research into disease development.

‘Major contribution to global stem cell research’

King’s has already developed eight clinical-grade and more than 30 research-grade stem cell lines, which were approved by the UK Stem Cell Steering Committee to be deposited with the UK Stem Cell Bank (UKSCB) and distributed worldwide.


Share this post:

If you are a possible stem cell patient, find ways to get a stem cell cure to have much better health and youthfulness

If you're a medical doctor and would like to learn and incorporate various stem cell treatments into your medical practice, be sure to get the proper stem cell medical training


Recent Posts

© 2023 Get Stem Cell Treatments. All rights reserved.

WordPress Theme by Theme Junkie